In clinical practice a patient's iron stores are often assessed by the analysis of serum iron, transferrin, and ferritin concentrations in conjunction with a full blood count measured on a blood sample anticoagulated with EDTA. ' Previous work has shown that the collection of the anticoagulated contents of the EDTA tube before that of the whole blood tube can leave traces of EDTA on the subsequent tube.2 Even at this low level of EDTA contamination in the serum sample, the iron is chelated by the EDTA and its reaction with the Ferrozine colorimetric reagent is inhibited, producing erroneously low serum iron concentrations. This type of EDTA interference can be prevented by the addition of zinc sulphate to the ascorbic acid reagent. 2 During sample preincubation with the ascorbic acid reagent, the zinc ions preferentially bind to the EDTA and leave the ferrous ions free to react with the Ferrozine reagent. In this situation the concentration of EDTA in the contaminated serum samples is unlikely to exceed 0-2 mmol/l and a zinc sulphate concentration of0 5 mmol/l effectively prevents the interference resulting from EDTA chelating the serum iron.
Obviously, it would sometimes be desirable to measure the plasma iron concentration in the same sample that is used for the full blood count. For example, whenever the full blood count unexpectedly suggests iron deficiency the plasma could be separated from the full blood count sample and analysed for iron, saving both time and money: there would be no need to recall the patient for a further blood sample. The routine use of a single sample for a full blood count and plasma iron would also minimise the blood volume required for these analyses and halve the number of sample collection tubes.
We describe a modification of a colorimetric iron method that permits the accurate measurement of iron in plasma samples anticoagulated with EDTA.
Methods
The iron concentration was measured in EDTA plasma from 24 patients with a range of serum iron concentrations from 5 to 33 imol/l. into the serum sample the EDTA anticoagulated blood sample was always collected after the whole blood sample. For the purpose of calculations it was assumed that 5 ml of blood collected into these tubes contained 2-5 ml of plasma and 7-5 mg EDTA (7 3mmol/1 EDTA). To assess the effect of sample volume we measured the iron concentrations in plasma from underfilled 5 ml EDTA blood collectior tubes. Six plasma samples were prepared from tubes containing 5 ml, 4 ml, 3 ml, 2 ml, 1 ml and 0 5 ml ofwhole blood. In these samples the calculated plasma concentrations of EDTA 7-3, 9-3, 12-2, 18 3, and 73-3 mmol/l, respectively. The apparent iron concentrations in these samples were measured using Method E. The results are summarised in fig 2 which shows that the measured plasma iron concentrations increased as the sample volume decreased from 5 ml to 1 ml and then sharply decreased at a sample volume of 05 ml. At a 0 5 ml sample volume, the EDTA concentration is 10 times higher than the 5 ml sample and the iron response is suppressed due to chelation. As the blood collection tubes are contaminated with 90 ng of iron underfilling will result in an increased plasma iron concentration of 0-63, 0-79, 1-05, 1-58, 3-15 and 6-30 umol/l, respectively. For blood volumes of > 1 ml, correcting the measured plasma iron result for this contamination gives a plasma iron concentration that is comparable with the corresponding serum iron result (fig 2) . Table 1 shows that there are two major differences in the composition of the Roche and Boehringer reagents. The Boehringer reagent contains thiourea and a much lower concentration of Ferrozine. As the Boehringer reagent gave no response to iron in EDTA samples ( fig  1) , we tested the effect of adding zinc and Ferrozine to this reagent (table 3) . In contrast to the Roche reagent, the addition of zinc did not abolish the EDTA effect, but increasing the Ferrozine concentration to that in the Roche reagent (1-9 mM) resulted in a similar response from both methods, and a further increase in the Ferrozine concentration almost abolished the EDTA effect. The addition of thiourea to the Roche reagent had no clinically relevant f impact. Discussion f Because samples for iron studies are often collected in conjunction with an EDTA sample for a full blood count any interference as a result of iron chelation is undesirable. Previous work on the interference of EDTA in colorimetric iron assays documents the effect of e EDTA contamination at a concentration of a 0-2 mmol/l in serum samples collected after an EDTA sample.2 These studies showed that the addition of 0-5 mmol/l of zinc sulphate to the ascorbic acid reagent prevents this type of e EDTA interference. In contrast, the EDTA in plasma collected for a full blood count is about 40-fold higher (7-3 mmol/l).
At pH 7, the stability constant of the zinc sulphate, EDTA binding is 100-fold greater than for the iron EDTA complex.6 In contrast, Ferrozine preferentially binds to iron. Therefore the addition of excess zinc sulphate to an iron reagent will enhance the formation of the iron Ferrozine complex even in the presence of EDTA. We added zinc sulphate (7 mmol/l) to a Roche reagent to equal twice the molar concentration of EDTA present in the reaction after the addition of a plasma sample containing 7-3 mmol/l EDTA. In this phase of the reaction the release of iron from transferrin is accelerated by guanidine hydrochloride, and the added zinc ions competitively inhibit chela-tion of the released iron by EDTA. Therefore, when Ferrozine is added, the iron is free to react. Due to the lower concentrations of Ferrozine, however, the addition of zinc had no effect on the Boehringer reagent. Although an increase in the concentration of Ferrozine to 6-0 mM abolishes the EDTA effect, it is both more convenient and much cheaper to prepare a modified reagent by the addition of zinc sulphate.
All the evacuated EDTA anticoagulated collection tubes that we tested contained iron contamination. Thus laboratories that wish to measure iron in EDTA plasma should be mindful of this potential problem and measure the level of contamination in their own batches of EDTA tubes. With the knowledge that plasma iron can now be measured in plasma from these tubes the manufacturers may be able to produce tubes free of iron contamination. However, where the observed contamination level is low, this can be ignored as it results in a minimal systematic error when the collection tubes are filled. When the tubes are underfilled the plasma iron concentration apparently increases until at a blood volume of < 1 ml per 5 ml tube even the modified reagent is unable to prevent the interference due to the very high concentration of EDTA present. Fortunately, this type ofunderfilled sample is also unsuitable for the full blood count and in practice should not be commonly encountered.
Our modified reagent system effectively overcomes the EDTA interference and permits the accurate measurement of plasma iron in samples being used for a full blood count. To perform complete iron studies on this sample the iron saturation can be calculated using the transferrin concentration measured by an immunoassay. While ferritin can also be measured in EDTA plasma, it must be remembered that EDTA interferes with its measurement by several enzyme immunoassays that utilise alkaline phosphatase as the label. By using the appropriate immunoassays in combination with a commercial iron reagent modified by the inclusions ofzinc, however, it is possible to use a single sample for a full blood count plus full iron studies. This has practical advantages and should result in savings of both time and money.
